CD274 and diffuse large B-cell lymphoma: 89Zr-labeled anti-PD-L1 antibodies including atezolizumab (anti-PD-L1 antibody, Tecentriq Roche), have also been used in clinical trials on advanced solid tumors and diffuse large B-cell lymphoma.